KR102300897B1 - Manufacturing method of solid phase schizandra concentration - Google Patents
Manufacturing method of solid phase schizandra concentration Download PDFInfo
- Publication number
- KR102300897B1 KR102300897B1 KR1020190130726A KR20190130726A KR102300897B1 KR 102300897 B1 KR102300897 B1 KR 102300897B1 KR 1020190130726 A KR1020190130726 A KR 1020190130726A KR 20190130726 A KR20190130726 A KR 20190130726A KR 102300897 B1 KR102300897 B1 KR 102300897B1
- Authority
- KR
- South Korea
- Prior art keywords
- schisandra
- concentrate
- mixing
- solid
- weight
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 title description 3
- 239000007790 solid phase Substances 0.000 title 1
- 241000736075 Schisandra Species 0.000 claims abstract description 66
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 65
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 239000012141 concentrate Substances 0.000 claims abstract description 28
- 239000007787 solid Substances 0.000 claims abstract description 27
- 238000002156 mixing Methods 0.000 claims abstract description 22
- 239000004480 active ingredient Substances 0.000 claims abstract description 21
- 238000001914 filtration Methods 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims abstract description 10
- 238000005119 centrifugation Methods 0.000 claims abstract description 7
- 238000001816 cooling Methods 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- 238000005406 washing Methods 0.000 claims abstract description 5
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 19
- 229920000858 Cyclodextrin Polymers 0.000 claims description 17
- 239000001116 FEMA 4028 Substances 0.000 claims description 17
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 17
- 229960004853 betadex Drugs 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims description 10
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 10
- 239000001099 ammonium carbonate Substances 0.000 claims description 10
- 235000012501 ammonium carbonate Nutrition 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000012153 distilled water Substances 0.000 claims description 8
- 239000001110 calcium chloride Substances 0.000 claims description 5
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 239000011148 porous material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 19
- 230000033558 biomineral tissue development Effects 0.000 abstract description 11
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 abstract description 7
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract description 7
- 229910001424 calcium ion Inorganic materials 0.000 abstract description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L calcium carbonate Substances [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000013543 active substance Substances 0.000 description 5
- 235000010216 calcium carbonate Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- RTZKSTLPRTWFEV-OLZOCXBDSA-N Deoxygomisin A Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@@H](C)[C@@H](C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-OLZOCXBDSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- ZWRRJEICIPUPHZ-MYODQAERSA-N gomisin a Chemical compound COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3C[C@](C)(O)[C@@H](C)CC2=CC2=C1OCO2 ZWRRJEICIPUPHZ-MYODQAERSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 238000003795 desorption Methods 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 238000002411 thermogravimetry Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- RTZKSTLPRTWFEV-UHFFFAOYSA-N Isokadsuranin Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)C(C)CC2=CC2=C1OCO2 RTZKSTLPRTWFEV-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 2
- 239000011365 complex material Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- BVMLGLOHSDNEJG-UHFFFAOYSA-N neglschisandrin E Natural products C1C(C)C(C)CC2=CC(O)=C(OC)C(OC)=C2C2=C1C=C1OCOC1=C2OC BVMLGLOHSDNEJG-UHFFFAOYSA-N 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- ZWRRJEICIPUPHZ-UHFFFAOYSA-N schisandrol B Natural products COC1=C2C=3C(OC)=C(OC)C(OC)=CC=3CC(C)(O)C(C)CC2=CC2=C1OCO2 ZWRRJEICIPUPHZ-UHFFFAOYSA-N 0.000 description 2
- 229930193195 schizandrin Natural products 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- 241000206761 Bacillariophyta Species 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001400472 Omiza Species 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000011173 biocomposite Substances 0.000 description 1
- 230000003592 biomimetic effect Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000007734 materials engineering Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/015—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/03—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
- A23L5/23—Removal of unwanted matter, e.g. deodorisation or detoxification by extraction with solvents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/51—Concentration
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/31—Mechanical treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/34—Membrane process
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/48—Ultrasonic treatment
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/50—Concentrating, enriching or enhancing in functional factors
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
본 발명은 고상의 오미자 농축물 제조방법에 관한 것으로서, 보다 상세하게는, 생광물화 프로세스를 모사하여 오미자로부터 유효성분을 추출하고, 고상의 농축물을 제조할 수 있는 고상의 오미자 농축물 제조방법에 관한 것이다. 이를 위해 고상의 오미자 농축물 제조방법은 오미자를 파쇄한 후, 에탄올과 혼합하고, 초음파로 오미자 내의 유효성분을 추출하는 제1단계; 상온에서 냉각한 후, 유효성분을 여과하는 제2단계; 여과물을 농축하여 오미자 추출물을 제조하는 제3단계; 오미자 추출물에 칼슘 이온을 포함하는 용액과 탄산 이온을 포함하는 용액을 첨가한 후 혼합하는 제4단계; 원심분리한 후, 에탄올로 세척하는 제5단계; 및 건조하여 고상의 오미자 농축물을 제조하는 제6단계;를 포함하는 것을 특징으로 한다.The present invention relates to a method for producing a solid Schisandra concentrate, and more particularly, to a method for preparing a solid Schisandra concentrate by extracting active ingredients from Schisandra by simulating the biomineralization process and preparing a solid concentrate. is about To this end, the solid Schisandra concentrate manufacturing method comprises: a first step of crushing Schisandra, mixing with ethanol, and extracting the active ingredient in Schisandra by ultrasonic waves; After cooling at room temperature, a second step of filtering the active ingredient; a third step of concentrating the filtrate to prepare a Schisandra extract; A fourth step of mixing after adding a solution containing calcium ions and a solution containing carbonate ions to the Schisandra extract; After centrifugation, a fifth step of washing with ethanol; and a sixth step of drying to prepare a solid Schisandra concentrate.
Description
본 발명은 고상의 오미자 농축물 제조방법에 관한 것으로서, 보다 상세하게는, 생광물화 프로세스를 모사하여 오미자로부터 유효성분을 추출하고, 고상의 농축물을 제조할 수 있는 고상의 오미자 농축물 제조방법에 관한 것이다.The present invention relates to a method for producing a solid Schisandra concentrate, and more particularly, to a method for preparing a solid Schisandra concentrate by extracting active ingredients from Schisandra by simulating the biomineralization process and preparing a solid concentrate. is about
오미자의 주요 생리활성 물질(약효성분)은 폴리페놀의 일종인 리그난(lignan) 성분으로 쉬잔드린(schizandrin), 고미신 A(gomisin A), 고미신 N(gomisin N) 등이 있으며, 식품의약품안전처 생약연구과에 한약재 품질 표준화 자료집에서 오미자 열매를 추출하였을 때 쉬잔드린(schizandrin), 고미신 A(gomisin A), 고미신 N(gomisin N)의 합이 0.7% 이상이라는 함량기준을 명시하고 있다. 이러한 오미자의 생리활성 물질은 추출 방법에 따라 수율에 높은 차이를 보이는데, 특히, 물로 추출했을 경우, 에탄올이나 메탄올로 추출했을 때보다 0.02 ~ 42% 가량 낮은 함량을 보이는 것으로 알려져 있다. 따라서 추출공정 개선이나 농축액 함유량을 높이는 방법이 필요한 실정이다. The main physiologically active substances (medicinal ingredients) of omija are lignans, a type of polyphenol, and include schizandrin, gomisin A, and gomisin N. According to the Herbal Medicine Research Division, the content standard that the sum of schizandrin, gomisin A, and gomisin N is more than 0.7% when Schisandra fruit is extracted from the herbal medicine quality standardization data book. These physiologically active substances of Schisandra show a high difference in yield depending on the extraction method. In particular, when extracted with water, it is known that the content is 0.02 to 42% lower than when extracted with ethanol or methanol. Therefore, there is a need for a method to improve the extraction process or increase the concentration of the concentrate.
생광물화(biomineralization)란 살아있는 생물이 광물을 만들어내는 과정을 말하는 것으로, 이로 인해 기존 조직은 종종 경도(硬度)나 강도(剛度)가 높아지는데 그러한 조직을 광물화 조직이라 한다. 생광물화는 매우 널리 퍼져 있는 현상으로 조류(藻類)와 규조류의 규산염, 무척추동물의 탄산염, 척추동물의 인산칼슘 및 탄산염이 있다. 조개껍질, 포유류나 조류(鳥類)의 뼈와 같은 구조적 특징은 종종 이러한 광물로 인해 만들어진다. 분류학적 분포 면에서 가장 흔한 생체광물은 탄산칼슘으로, 이들은 콜라겐(collagen) 및 키틴(chitin)과 같은 유기 중합체와 함께 뼈나 조개껍질을 구조적으로 지탱하기 위해 이용되고 있다. 이러한 생물 복합재료로 이루어진 구조는 나노미터부터 현미경 수준에 이르기까지 고도로 조절되며 그 결과 기능이 다양하고 복잡한 구조물이 형성된다. 생물이 조절하는 생광물화 메커니즘을 이해하고 명료하게 밝히는 데 상당한 관심을 기울이는 이유는 응용재료공학에서 이런 방식으로 광물 생성을 조절할 필요가 있기 때문이다.Biomineralization refers to the process by which living organisms make minerals, which often increases the hardness or strength of existing tissues. Such tissues are called mineralized tissues. Biomineralization is a very widespread phenomenon, with silicates in algae and diatoms, carbonates in invertebrates, and calcium phosphates and carbonates in vertebrates. Structural features, such as shells and bones of mammals and birds, are often created from these minerals. In terms of taxonomic distribution, the most common biomineral is calcium carbonate, which, together with organic polymers such as collagen and chitin, is used to structurally support bones and shells. The structures made of these biocomposites are highly controlled from the nanometer to the microscopic level, resulting in complex structures with diverse functions. The reason for considerable interest in understanding and elucidating biomineralization mechanisms regulated by organisms is the need to control mineral production in this way in applied materials engineering.
특히, 생체 모방형 생광물화 과정은 인회석(apatites)과 같은 물질을 생산하는 자연의 방식을 모방하는 것을 말한다. 광물의 상은 순수하지 않지만 유기부분을 수반하는 복합 물질이 만들어지는데, 이 복합 물질은 생광물화에 참여하며 조절된다. 따라서 유기물과 생광물화 과정의 조합으로 다양한 복합물질을 설계할 수 있으며, 이들은 유기물질과 더불어 디자인되어 침전되는 결과물을 가져다준다. 이들의 과정에 착안하여 유기물 복합 물질인 오미자 추출물을 분리, 정제, 농축하여 고상 형태의 오미자 농축물을 제조하는 방법을 착안하게 되었다.In particular, the biomimetic biomineralization process refers to mimicking nature's way of producing materials such as apatites. The phase of the mineral is not pure, but a complex material with organic parts is produced, which is controlled and participates in biomineralization. Therefore, various composite materials can be designed by combining organic materials and biomineralization processes, and these are designed together with organic materials, resulting in precipitation. Focusing on these processes, a method for preparing a Schisandra concentrate in a solid form was conceived by separating, purifying, and concentrating the Schisandra extract, which is an organic complex material.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 본 발명의 목적은 생광물화 공정에 착안하여 추출 방법에 따라 높은 수득율의 차이를 보이는 종래 제조방법의 단점을 극복하고, 고상 형태의 오미자 농축물을 제조할 수 있는 고상의 오미자 농축물 제조방법을 제공하는데 있다.The present invention is to solve the above problems, and an object of the present invention is to overcome the disadvantages of the conventional manufacturing method showing a high difference in yield depending on the extraction method by focusing on the biomineralization process, and to overcome the disadvantages of the Schisandra concentrate in solid form An object of the present invention is to provide a method for preparing a solid Schisandra concentrate that can produce
본 발명의 상기 및 다른 목적과 이점은 바람직한 실시예를 설명한 하기의 설명으로부터 분명해질 것이다.These and other objects and advantages of the present invention will become apparent from the following description of preferred embodiments.
상기 목적은, 오미자를 파쇄한 후, 에탄올과 혼합하고, 초음파로 오미자 내의 유효성분을 추출하는 제1단계; 상온에서 냉각한 후, 유효성분을 여과하는 제2단계; 여과물을 농축하여 오미자 추출물을 제조하는 제3단계; 오미자 추출물에 칼슘 이온을 포함하는 용액과 탄산 이온을 포함하는 용액을 첨가한 후 혼합하는 제4단계; 원심분리한 후, 에탄올로 세척하는 제5단계; 및 건조하여 고상의 오미자 농축물을 제조하는 제6단계;를 포함하는 고상의 오미자 농축물 제조방법에 의해 달성될 수 있다.The object is, after crushing Schisandra, a first step of mixing with ethanol, and extracting the active ingredients in Schisandra by ultrasonic waves; After cooling at room temperature, a second step of filtering the active ingredient; a third step of concentrating the filtrate to prepare a Schisandra extract; A fourth step of mixing after adding a solution containing calcium ions and a solution containing carbonate ions to the Schisandra extract; After centrifugation, a fifth step of washing with ethanol; and a sixth step of drying to prepare a solid Schisandra concentrate.
이때, 제1단계에서 오미자와 에탄올은 1 : 5~15의 중량비로 혼합할 수 있고, 초음파 추출은 50~70℃의 온도에서 60~120분 동안 수행될 수 있다.At this time, in the first step, omiza and ethanol may be mixed in a weight ratio of 1: 5-15, and ultrasonic extraction may be performed at a temperature of 50-70° C. for 60-120 minutes.
또한, 제3단계에서 오미자 추출물은 40~50℃의 온도 및 60~80 mbar의 압력 조건에서 농축되어 제조될 수 있다.In addition, in the third step, the Schisandra extract may be prepared by being concentrated at a temperature of 40-50° C. and a pressure of 60-80 mbar.
또한, 제4단계에서 칼슘 이온을 포함하는 용액은 염화칼슘(CaCl2) 수용액이고, 탄산 이온을 포함하는 용액은 탄산암모늄((NH4)2CO3) 수용액일 수 있다. 바람직하게, 염화칼슘(CaCl2) 수용액은 증류수 100 중량부에 대해서 염화칼슘 0.1~5.0 중량부를 혼합하여 제조할 수 있고, 탄산암모늄((NH4)2CO3) 수용액은 증류수 100 중량부에 대해서 탄산암모늄 0.1~5.0 중량부를 혼합하여 제조할 수 있다.In addition, in the fourth step, the solution containing calcium ions is calcium chloride (CaCl 2 ) aqueous solution, and the solution containing carbonate ions is ammonium carbonate ((NH 4 ) 2 CO 3 ) aqueous solution. Preferably, calcium chloride (CaCl 2 ) aqueous solution can be prepared by mixing 0.1 to 5.0 parts by weight of calcium chloride with respect to 100 parts by weight of distilled water, and ammonium carbonate ((NH 4 ) 2 CO 3 ) aqueous solution is ammonium carbonate with respect to 100 parts by weight of distilled water. It can be prepared by mixing 0.1 to 5.0 parts by weight.
또한, 제6단계의 건조는 50~70℃의 온도에서 수행될 수 있다.In addition, the drying of the sixth step may be performed at a temperature of 50 ~ 70 ℃.
또한, 제3단계와 제4단계 사이에, 오미자 추출물을 베타-사이클로덱스트린(β-cyclodextrin)과 혼합하는 단계;를 더 포함할 수 있고, 베타-사이클로덱스트린(β-cyclodextrin)은 증류수 100 중량부에 대해서 베타-사이클로덱스트린 0.1~10.0 중량부를 혼합하여 제조할 수 있다.In addition, between the third and fourth steps, mixing the Schisandra extract with beta-cyclodextrin (β-cyclodextrin) may further include; beta-cyclodextrin (β-cyclodextrin) is 100 parts by weight of distilled water It can be prepared by mixing 0.1 to 10.0 parts by weight of beta-cyclodextrin.
본 발명에 따르면, 오미자로부터 생리활성 물질(유효성분)을 효과적으로 추출할 수 있는 효과를 가진다.According to the present invention, it has the effect of effectively extracting a physiologically active substance (active ingredient) from Schisandra.
구체적으로, 생광물화 공정을 착안하여 개발함으로써 종래의 방법에 비해 간단하고, 수득율이 높으며, 고상의 형태로 오미자 농축물을 제조할 수 있는 효과를 가진다.Specifically, by focusing on the biomineralization process and developing it, it is simpler than the conventional method, the yield is high, and has the effect of being able to prepare the Schisandra concentrate in a solid form.
나아가, 본 발명에 의해 제조된 고상의 오미자 농축물은 식품 소재 및 화장품 소재 등 여러 가지 분야에 응용될 수 있어 식품 산업 및 화장품 산업의 성장에 기여할 수 있는 효과를 가진다.Furthermore, the solid Schisandra concentrate prepared by the present invention can be applied to various fields such as food materials and cosmetic materials, and has the effect of contributing to the growth of the food industry and cosmetic industry.
다만, 본 발명의 효과들은 이상에서 언급한 효과로 제한되지 않으며, 언급되지 않은 또 다른 효과들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.However, the effects of the present invention are not limited to the above-mentioned effects, and other effects not mentioned will be clearly understood by those skilled in the art from the following description.
도 1은 본 발명의 일 실시예에 따른 고상의 오미자 농축물 제조방법을 개략적으로 나타낸 도면이다.
도 2는 실시예의 SEM 사진이다.
도 3은 비교예의 SEM 사진이다.
도 4는 실시예의 BET 표면적을 나타낸 그래프이다.
도 5는 실시예의 Isotherm linear plot 그래프이다.
도 6은 실시예의 BJH 흡착 특성을 분석한 그래프이다.
도 7은 실시예의 BJH 탈착 특성을 분석한 그래프이다.
도 8은 실시예의 PSA 결과를 나타낸 그래프이다.
도 9는 실시예의 XRD 분석을 나타낸 그래프이다.
도 10은 실시예의 TGA 분석을 나타낸 그래프이다.1 is a view schematically showing a method for preparing a solid Schisandra concentrate according to an embodiment of the present invention.
2 is an SEM photograph of the embodiment.
3 is an SEM photograph of a comparative example.
4 is a graph showing the BET surface area of the Example.
5 is an Isotherm linear plot graph of the embodiment.
6 is a graph analyzing the BJH adsorption characteristics of Examples.
7 is a graph analyzing the BJH desorption characteristics of Examples.
8 is a graph showing the PSA results of Examples.
9 is a graph showing the XRD analysis of Examples.
10 is a graph showing the TGA analysis of Examples.
이하, 본 발명의 실시예와 도면을 참조하여 본 발명을 상세히 설명한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위해 예시적으로 제시한 것일 뿐, 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 당업계에서 통상의 지식을 가지는 자에 있어서 자명할 것이다.Hereinafter, the present invention will be described in detail with reference to embodiments and drawings of the present invention. It will be apparent to those of ordinary skill in the art that these examples are only presented by way of example to explain the present invention in more detail, and that the scope of the present invention is not limited by these examples. .
또한, 달리 정의하지 않는 한, 본 명세서에서 사용되는 모든 기술적 및 과학적 용어는 본 발명이 속하는 기술 분야의 숙련자에 의해 통상적으로 이해되는 바와 동일한 의미를 가지며, 상충되는 경우에는, 정의를 포함하는 본 명세서의 기재가 우선할 것이다.Further, unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs, and in case of conflict, this specification, including definitions description will take precedence.
도면에서 제안된 발명을 명확하게 설명하기 위해서 설명과 관계없는 부분은 생략하였으며, 명세서 전체를 통하여 유사한 부분에 대해서는 유사한 도면 부호를 붙였다. 그리고, 어떤 부분이 어떤 구성 요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성 요소를 제외하는 것이 아니라 다른 구성 요소를 더 포함할 수 있는 것을 의미한다. 또한, 명세서에서 기술한 "부"란, 특정 기능을 수행하는 하나의 단위 또는 블록을 의미한다.In order to clearly explain the invention proposed in the drawings, parts irrelevant to the description are omitted, and similar reference numerals are attached to similar parts throughout the specification. And, when a part "includes" a certain component, this means that other components may be further included, rather than excluding other components, unless otherwise stated. In addition, "unit" described in the specification means one unit or block that performs a specific function.
각 단계들에 있어 식별부호(제1, 제2, 등)는 설명의 편의를 위하여 사용되는 것으로 식별부호는 각 단계들의 순서를 설명하는 것이 아니며, 각 단계들은 문맥상 명백하게 특정 순서를 기재하지 않는 이상 명기된 순서와 다르게 실시될 수 있다. 즉, 각 단계들은 명기된 순서와 동일하게 실시될 수도 있고 실질적으로 동시에 실시될 수도 있으며 반대의 순서대로 실시될 수도 있다.In each step, the identification number (first, second, etc.) is used for convenience of description, and the identification number does not describe the order of each step, and each step does not clearly describe a specific order in context. It may be performed differently from the order specified above. That is, each step may be performed in the same order as specified, may be performed substantially simultaneously, or may be performed in the reverse order.
도 1은 본 발명의 일 실시예에 따른 고상의 오미자 농축물 제조방법을 개략적으로 나타낸 도면이다. 도 1을 참조하여 설명하면, 본 발명의 일 실시예에 따른 고상의 오미자 농축물 제조방법은 오미자를 파쇄한 후, 에탄올과 혼합하고, 초음파로 오미자 내의 유효성분을 추출하는 제1단계; 상온에서 냉각한 후, 유효성분을 여과하는 제2단계; 여과물을 농축하여 오미자 추출물을 제조하는 제3단계; 오미자 추출물에 칼슘 이온을 포함하는 용액과 탄산 이온을 포함하는 용액을 첨가한 후 혼합하는 제4단계; 원심분리한 후, 에탄올로 세척하는 제5단계; 및 건조하여 고상의 오미자 농축물을 제조하는 제6단계;를 포함한다. 본 발명은 생광물화 공정을 착안한 것으로서, 종래의 방법에 비해 간단하고, 수득율이 높으며, 오미자로부터 생리활성 물질(유효성분)을 효과적으로 추출하여 고상 형태의 오미자 농축물을 제조할 수 있는 효과를 가진다.1 is a view schematically showing a method for producing a solid Schisandra concentrate according to an embodiment of the present invention. Referring to FIG. 1 , a method for producing a solid Schisandra concentrate according to an embodiment of the present invention comprises: a first step of crushing Schisandra, mixed with ethanol, and extracting the active ingredients in Schisandra by ultrasonic waves; After cooling at room temperature, a second step of filtering the active ingredient; a third step of concentrating the filtrate to prepare a Schisandra extract; A fourth step of mixing after adding a solution containing calcium ions and a solution containing carbonate ions to the Schisandra extract; After centrifugation, a fifth step of washing with ethanol; and a sixth step of drying to prepare a solid Schisandra concentrate. The present invention focuses on the biomineralization process, which is simpler and has a higher yield than the conventional method, and has the effect of effectively extracting a physiologically active substance (active ingredient) from Schisandra Schisandra to produce a solid form of Schisandra concentrate. have
제1단계는, 오미자 내의 생리활성 물질을 추출하는 단계로, 용매로 에탄올을 사용하고, 초음파 추출 방식을 이용한다. 에탄올을 용매로 사용할 경우, 물을 사용하여 추출할 때보다 높은 함량의 유효성분을 추출할 수 있다. 구체적으로, 오미자를 파쇄하고, 약 70% 농도의 에탄올과 1 : 5~15의 중량비로 혼합한 후, 50~70℃의 온도에서 60~120분 동안 초음파를 이용하여 유효성분을 추출할 수 있다.The first step is to extract the physiologically active substances in Schisandra, using ethanol as a solvent and ultrasonic extraction method. When ethanol is used as a solvent, a higher content of active ingredients can be extracted than when extraction is performed using water. Specifically, after crushing omija and mixing it with ethanol having a concentration of about 70% in a weight ratio of 1 : 5 to 15, the active ingredient can be extracted using ultrasound at a temperature of 50 to 70 ° C for 60 to 120 minutes. .
제2단계는, 초음파를 이용하여 추출한 유효성분이 포함된 액체 성분을 상온(20~30℃를 의미함)에서 냉각하고, 여과하는 단계이다. 이때, 여과는 여과막을 사용할 수 있고, 공지의 여러가지 여과막을 사용할 수 있으며, 약 3.0㎛의 공극을 가진 여과막을 사용하는 것이 바람직하다.The second step is a step of cooling and filtering the liquid component containing the active ingredient extracted using ultrasonic waves at room temperature (meaning 20-30°C). At this time, a filtration membrane may be used for filtration, and various known filtration membranes may be used, and it is preferable to use a filtration membrane having pores of about 3.0 μm.
제3단계는, 여과된 유효성분이 포함된 여과물을 1차적으로 농축하여 오미자 추출물을 제조하는 단계이다. 이때, 1차 농축과정은 40~50℃의 온도 및 60~80 mbar의 압력 조건에서 수행될 수 있고, 이를 통해 유효성분들이 서로 뒤엉킨 상태로 농축된 오미자 추출물을 제조할 수 있다.The third step is to prepare a Schisandra extract by first concentrating the filtrate containing the filtered active ingredient. In this case, the first concentration process may be performed at a temperature of 40-50° C. and a pressure of 60-80 mbar, and through this, a concentrated Schisandra extract can be prepared in a state in which the active ingredients are entangled with each other.
제3단계 이후의 과정은 1차적으로 농축된 오미자 추출물을 분리 및 정제하고 보다 농축하여 고상 형태의 오미자 농축물을 제조하는 단계이다. The process after the third step is to prepare a solid form of Schisandra concentrate by first separating and purifying the concentrated Schisandra extract, and further concentrating it.
제4단계는 제3단계에서 제조된 오미자 추출물에 칼슘 이온을 포함하는 용액과 탄산 이온을 포함하는 용액을 첨가한 후 혼합하는 단계이다. 칼슘 이온과 탄산 이온이 결합되어 탄산칼슘이 형성되고, 형성된 탄산칼슘은 오미자 추출물을 둘러싸게 된다. 이에 따라, 오미자 추출물은 다른 성분들과 분리되어 침전된다. 이때, 칼슘 이온을 포함하는 용액은 염화칼슘(CaCl2) 수용액을 사용할 수 있고, 탄산 이온을 포함하는 용액은 탄산암모늄((NH4)2CO3) 수용액을 사용할 수 있으며, 각각 증류수 100 중량부에 대해서 염화칼슘 0.1~5.0 중량부와 탄산암모늄 0.1~5.0 중량부를 혼합하여 제조하는 것이 바람직하다.The fourth step is a step of mixing after adding a solution containing calcium ions and a solution containing carbonate ions to the Schisandra extract prepared in the third step. Calcium ions and carbonate ions combine to form calcium carbonate, and the formed calcium carbonate surrounds the Schisandra extract. Accordingly, the Schisandra extract is separated from other components and precipitated. At this time, the solution containing calcium ions may use an aqueous solution of calcium chloride (CaCl 2 ), and the solution containing carbonate ions may use an aqueous solution of ammonium carbonate ((NH 4 ) 2 CO 3 ), each in 100 parts by weight of distilled water. It is preferable to prepare by mixing 0.1 to 5.0 parts by weight of calcium chloride and 0.1 to 5.0 parts by weight of ammonium carbonate.
바람직하게, 제3단계와 제4단계 사이에, 오미자 추출물을 베타-사이클로덱스트린(β-cyclodextrin)과 혼합하는 단계;를 더 포함할 수 있다. 오미자 추출물과 베타-사이클로덱스트린(β-cyclodextrin)을 혼합함으로써 소수성인 유효성분을 더욱 결합시키는 효과를 가질 수 있다. 따라서, 오미자로부터 추출된 유효성분을 효과적으로 결합시킬 수 있다면, 다른 용액을 사용하는 것도 가능하다. 베타-사이클로덱스트린(β-cyclodextrin)은 소수성 성분을 효과적으로 결합시킬 수 있도록 증류수 100 중량부에 대해서 베타-사이클로덱스트린 0.1~10.0 중량부를 혼합하여 제조된 것을 사용하는 것이 바람직하다.Preferably, between the third step and the fourth step, the step of mixing the Schisandra extract with beta-cyclodextrin (β-cyclodextrin) may be further included. By mixing Schisandra extract and beta-cyclodextrin (β-cyclodextrin), it can have the effect of further binding the hydrophobic active ingredient. Therefore, if the active ingredient extracted from Schisandra can be effectively combined, it is possible to use other solutions. It is preferable to use beta-cyclodextrin (β-cyclodextrin) prepared by mixing 0.1 to 10.0 parts by weight of beta-cyclodextrin with respect to 100 parts by weight of distilled water to effectively bind the hydrophobic component.
제5단계는, 탄산칼슘에 의해 둘러싸인 오미자 추출물을 원심분리한 후, 에탄올로 세척하는 단계이다. 원심분리는 다양한 조건의 공지된 방법을 이용할 수 있으며, 원심분리한 후, 에탄올로 적어도 2회 이상 세척하는 것이 바람직하다.Step 5 is a step of centrifuging the Schisandra extract surrounded by calcium carbonate, followed by washing with ethanol. Centrifugation may use a known method under various conditions, and after centrifugation, it is preferable to wash at least twice with ethanol.
제6단계는, 에탄올로 세척된 물질을 건조하여 고상의 오미자 농축물을 제조하는 단계이다. 건조는 드라이 오븐을 이용할 수 있으나, 이제 제한되는 것은 아니고, 다양한 건조 방법을 사용할 수 있다. 건조단계는 50~70℃의 온도에서 수행되는 것이 바람직하고, 건조단계를 거치게 됨으로써 고상의 오미자 농축물을 얻을 수 있다.The sixth step is to prepare a solid Schisandra concentrate by drying the material washed with ethanol. Drying may use a dry oven, but is not limited thereto, and various drying methods may be used. The drying step is preferably performed at a temperature of 50 to 70° C., and by going through the drying step, a solid Schisandra concentrate can be obtained.
이하, 구체적인 실시예와 비교예를 통하여 본 발명의 구성 및 그에 따른 효과를 보다 상세히 설명하고자 한다. 그러나, 본 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것이며, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the configuration of the present invention and its effects will be described in more detail through specific examples and comparative examples. However, these examples are for explaining the present invention in more detail, and the scope of the present invention is not limited to these examples.
[재료준비][Material preparation]
필요한 시약으로 염화칼슘(CaCl2), 탄산암모늄((NH4)2CO3)은 시그마에서 구매하였고, 베타-사이클로덱스티린(β-cyclodextrin, β-CD), 에탄올은 대정에서 구입하였다.Calcium chloride (CaCl 2 ) and ammonium carbonate ((NH 4 ) 2 CO 3 ) as necessary reagents were purchased from Sigma, beta-cyclodextrin (β-cyclodextrin, β-CD), and ethanol were purchased from Daejeong.
[실시예][Example]
아래와 같은 순서로 고상의 오미자 농축물을 제조하였다.A solid Schisandra concentrate was prepared in the following order.
1. 파쇄한 오미자 100g을 70% 에탄올 1,000g과 혼합한 후, 60℃에서 90분 동안 초음파를 이용하여 유효성분을 추출하였다.1. After mixing 100 g of crushed omija with 1,000 g of 70% ethanol, the active ingredient was extracted using ultrasonic waves at 60° C. for 90 minutes.
2. 추출된 유효성분을 30℃에서 냉각한 후, 3.0㎛ 공극의 여과막을 이용하여 여과하였다.2. After cooling the extracted active ingredient at 30° C., it was filtered using a 3.0 μm pore filtration membrane.
3. 여과물을 45℃의 온도 및 70 mbar의 압력 조건에서 1차적으로 농축하여 오미자 추출물을 제조하였다.3. The filtrate was first concentrated at a temperature of 45° C. and a pressure of 70 mbar to prepare a Schisandra extract.
4. β-CD(1.2 g/100 mL DW)를 병에 넣고 녹인 후, 오미자 추출물이 포함된 용액 15mL와 혼합하고, 2시간 30분 동안 교반하였다.4. β-CD (1.2 g/100 mL DW) was put in a bottle and dissolved, mixed with 15 mL of a solution containing Schisandra extract, and stirred for 2 hours and 30 minutes.
5. 염화칼슘(CaCl2, 1.1 g/100 mL DW) 용액을 넣은 후 30분 동안 교반하였다.5. Calcium chloride (CaCl 2 , 1.1 g/100 mL DW) solution was added and stirred for 30 minutes.
6. 이어서, 탄산암모늄((NH4)2CO3, 0.96 g/100 mL DW) 용액을 넣은 후 10분 동안 교반하였다.6. Then, ammonium carbonate ((NH 4 ) 2 CO 3 , 0.96 g/100 mL DW) solution was added and stirred for 10 minutes.
7. 원심분리한 후, 에탄올로 2번 세척하였고, 샘플을 수집하였다.7. After centrifugation, it was washed twice with ethanol, and samples were collected.
8. 샘플을 드라이어븐(60℃)에 넣고 건조시켜 고상의 오미자 농축물을 제조하였고, 그 후, 상온에서 보관하였다.8. The sample was put in a dryer (60° C.) and dried to prepare a solid Schisandra concentrate, and then stored at room temperature.
[비교예][Comparative example]
상기 실시예의 1~3번까지의 과정만 수행한 후, 오미자 추출물을 제조하였다.After performing
[실험예][Experimental example]
SEM 이미지 분석SEM image analysis
실시예 및 비교예의 SEM 사진을 비교하였다(도 2 및 도 3 참조).SEM photographs of Examples and Comparative Examples were compared (see FIGS. 2 and 3).
실시예가 입자 형태를 보인 반면, 비교예는 젤의 형태를 보였다.While the Example showed the particle form, the Comparative Example showed the gel form.
BET 표면적, BJH 흡착 및 탈착 분석BET surface area, BJH adsorption and desorption analysis
도 4 내지 도 7은 각각 실시예의 BET 표면적, Isotherm linear plot, BJH 흡착, BJH 탈착 특성을 분석한 도면으로, 표면적이 5.559 m2/g, pore 부피가 0.015 cm3/g로 메조포러스한 특징을 지닌다는 것을 확인하였다.4 to 7 are diagrams analyzing the BET surface area, Isotherm linear plot, BJH adsorption, and BJH desorption characteristics of Examples, respectively, showing mesoporous characteristics with a surface area of 5.559 m 2 /g and a pore volume of 0.015 cm 3 /g confirmed that it has
PSA(particle size analyzer) 분석Particle size analyzer (PSA) analysis
도 8은 실시예의 PSA 결과를 나타낸 도면으로 입자 크기의 분포도를 나타낸다. 평균 직경이 17.59ㅁ19.46㎛로서 매우 불규칙한 형태의 마이크로 크기의 입자임을 확인할 수 있었다.8 is a diagram showing the PSA results of Examples and shows the distribution of particle sizes. It could be confirmed that the average diameter was 17.59ㅁ19.46㎛, and it was a very irregularly shaped micro-sized particle.
XRD 분석XRD analysis
도 9는 실시예의 XRD 분석을 나타낸 도면으로, 이를 통해 실시예는 비결정성 입자임을 확인할 수 있었다.9 is a view showing the XRD analysis of the example, through which it can be confirmed that the example is an amorphous particle.
TGA 분석TGA analysis
도 10은 실시예의 TGA 분석을 나타낸 도면으로, 이를 통해 1차적으로 농축된 오미자 추출물(비교예)로부터 유래된 유기물이 73.44 중량%인 것을 확인할 수 있었다.10 is a view showing the TGA analysis of the example, and through this, it was confirmed that the organic matter derived from the primarily concentrated Schisandra extract (Comparative Example) was 73.44 wt%.
생리활성 물질 농도 분석Analysis of concentration of bioactive substances
하기 표 1 및 표 2는 각각 실시예 및 비교예의 농도를 HPLC로 분석한 결과이다. 비교예의 경우, 2,638 ppm인 반면, 실시예는 8,680 ppm으로 3.3배 가량 농축되었다는 것을 확인할 수 있었다. Tables 1 and 2 below are the results of analyzing the concentrations of Examples and Comparative Examples by HPLC, respectively. In the case of the comparative example, it was confirmed that the concentration was about 3.3 times to 8,680 ppm, whereas the concentration was 2,638 ppm.
[표 1][Table 1]
[표 2][Table 2]
본 명세서에서는 본 발명자들이 수행한 다양한 실시예 가운데 몇 개의 예만을 들어 설명하는 것이나 본 발명의 기술적 사상은 이에 한정하거나 제한되지 않고, 당업자에 의해 변형되어 다양하게 실시될 수 있음은 물론이다.In this specification, only a few examples among the various embodiments performed by the present inventors are described, but the technical spirit of the present invention is not limited or limited thereto, and it is of course that it may be modified and variously implemented by those skilled in the art.
Claims (10)
상온에서 냉각한 후, 유효성분을 3.0 μm의 공극을 갖는 여과막을 사용하여 여과하는 제2단계;
여과물을 농축하여 오미자 추출물을 제조하는 제3단계;
상기 오미자 추출물을 증류수 100 중량부에 대해 베타-사이클로덱스트린 0.1 내지 10 중량부를 혼합하여 제조된 베타-사이클로덱스트린 용액과 혼합하는 제4단계;
상기 베타-사이클로덱스트린 용액과 혼합한 오미자 추출물에 염화칼슘 수용액과 탄산암모늄 수용액을 첨가한 후 혼합하는 제5단계;
원심분리한 후, 에탄올로 2회 이상 세척하는 제6단계; 및
드라이 오븐을 이용하여 50℃ 내지 70℃의 온도에서 건조하여 고상의 오미자 농축물을 제조하는 제7단계;
를 포함하는 것을 특징으로 하는, 고상의 오미자 농축물 제조방법.A first step of crushing Schisandra, mixing the crushed Schisandra with 70% concentration of ethanol, and extracting the active ingredient in Schisandra by ultrasonic wave at a temperature range of 50° C. to 70° C. for 60 minutes to 120 minutes;
After cooling at room temperature, a second step of filtering the active ingredient using a filtration membrane having a pore size of 3.0 μm;
a third step of concentrating the filtrate to prepare a Schisandra extract;
a fourth step of mixing the Schisandra extract with a beta-cyclodextrin solution prepared by mixing 0.1 to 10 parts by weight of beta-cyclodextrin with respect to 100 parts by weight of distilled water;
a fifth step of adding an aqueous solution of calcium chloride and an aqueous solution of ammonium carbonate to the omija extract mixed with the beta-cyclodextrin solution and then mixing;
After centrifugation, a sixth step of washing twice or more with ethanol; and
a seventh step of preparing a solid Schisandra concentrate by drying at a temperature of 50° C. to 70° C. using a dry oven;
A method for producing a solid omija concentrate, comprising:
제1단계에서 오미자와 에탄올은 1 : 5~15의 중량비로 혼합하는 것을 특징으로 하는, 고상의 오미자 농축물 제조방법.According to claim 1,
In the first step, omija and ethanol are mixed in a weight ratio of 1: 5-15, a method for producing a solid Schisandra concentrate.
제3단계에서 오미자 추출물은 40~50℃의 온도 및 60~80 mbar의 압력 조건에서 농축되어 제조되는 것을 특징으로 하는, 고상의 오미자 농축물 제조방법.According to claim 1,
In the third step, the Schisandra extract is concentrated at a temperature of 40-50° C. and a pressure of 60-80 mbar.
염화칼슘(CaCl2) 수용액은 증류수 100 중량부에 대해서 염화칼슘 0.1~5.0 중량부를 혼합하여 제조하는 것을 특징으로 하는, 고상의 오미자 농축물 제조방법.According to claim 1,
Calcium chloride (CaCl 2 ) aqueous solution is prepared by mixing 0.1 to 5.0 parts by weight of calcium chloride with respect to 100 parts by weight of distilled water.
탄산암모늄((NH4)2CO3) 수용액은 증류수 100 중량부에 대해서 탄산암모늄 0.1~5.0 중량부를 혼합하여 제조하는 것을 특징으로 하는, 고상의 오미자 농축물 제조방법.According to claim 1,
Ammonium carbonate ((NH 4 ) 2 CO 3 ) aqueous solution is prepared by mixing 0.1 to 5.0 parts by weight of ammonium carbonate with respect to 100 parts by weight of distilled water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190130726A KR102300897B1 (en) | 2019-10-21 | 2019-10-21 | Manufacturing method of solid phase schizandra concentration |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190130726A KR102300897B1 (en) | 2019-10-21 | 2019-10-21 | Manufacturing method of solid phase schizandra concentration |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20210047412A KR20210047412A (en) | 2021-04-30 |
KR102300897B1 true KR102300897B1 (en) | 2021-09-13 |
Family
ID=75740823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190130726A KR102300897B1 (en) | 2019-10-21 | 2019-10-21 | Manufacturing method of solid phase schizandra concentration |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102300897B1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972085B1 (en) * | 2018-09-17 | 2019-04-24 | (주)에이씨티 | Stabilizing method of Curcuma Longa Extracts and cosmetic composition containing the stabilized Curcuma Longa Extracts |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100849145B1 (en) * | 2006-08-23 | 2008-07-31 | 주식회사 마크로케어 | Method for extraction of genistein using cyclodextrin |
KR101026879B1 (en) * | 2010-09-24 | 2011-04-06 | 한국콜마 주식회사 | Producing method of cosmetic composition for improving skin wrinkle |
KR20130050536A (en) | 2011-11-08 | 2013-05-16 | 정세영 | Development of confectionery with a mixture of omija (schizandra chinensis baillon), tomato (solanum lycopersicum linnaeus), and apple (malus pumila var. dulcissima) concentrates |
KR102080204B1 (en) * | 2017-12-14 | 2020-02-21 | 한국화학연구원 | Clathrate compound of Schisandra chinensis extract and method for its production |
-
2019
- 2019-10-21 KR KR1020190130726A patent/KR102300897B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972085B1 (en) * | 2018-09-17 | 2019-04-24 | (주)에이씨티 | Stabilizing method of Curcuma Longa Extracts and cosmetic composition containing the stabilized Curcuma Longa Extracts |
Also Published As
Publication number | Publication date |
---|---|
KR20210047412A (en) | 2021-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR102125567B1 (en) | Large-Scale Production of Plant Derived Exosomes | |
JP7057042B2 (en) | Nanocomposite material | |
CN107109392A (en) | The method extracted and purify non-denatured protein matter | |
JP6046779B2 (en) | Rice protein composition and method for producing the same | |
Kaya et al. | Comparison of bovine serum albumin adsorption capacities of α-chitin isolated from an insect and β-chitin from cuttlebone | |
US7101996B2 (en) | Process for preparing purified fractions of hemicellulose and cellulose-hemicellulose complexes from alkali treated fiber and products made by the process | |
EP1968722A1 (en) | Method for separating proteins from liquid media | |
CN108251483B (en) | Preparation method of sea cucumber active peptide powder | |
DE10297399T5 (en) | New cellulose materials | |
CN114025619A (en) | Natural composite material derived from seaweed and method for producing the same | |
KR102300897B1 (en) | Manufacturing method of solid phase schizandra concentration | |
AU2021107526A4 (en) | The preparation method and application of malic acid-chitosan nanoporous hydrogel microspheres | |
CN108118560B (en) | Heavy metal ion filter paper and preparation method thereof | |
Meng et al. | Ionic liquid templated porous nano-TiO2 particles for the selective isolation of cytochrome c | |
Pratiwi et al. | Enhanced antibiofouling properties of chitosan-based membranes by coating and blending of Moringa Oleifera L extracts | |
KR101724118B1 (en) | Method for preparing high purity protein concentrate from rice bran | |
RU2613294C1 (en) | Method for producing melanin from sunflower husks | |
RU2714115C2 (en) | Polysaccharide microgel application during vegetable oil production, polysaccharide microgel based reagents and vegetable oil production method using thereof | |
RU2593479C1 (en) | Method of producing pectin | |
Hamzah et al. | Hydroxyapatite/chitosan biocomposite for Remazol blue dyes removal | |
CN112871101A (en) | Method for adjusting size of lignosulfonate nanorod | |
RU2360733C1 (en) | Method of obtaining composition sorbate for purificaion and concentration of biologically active anthocianins from plant raw material | |
RU2195488C2 (en) | Method of processing wine material | |
RU2413432C2 (en) | Method to produce arabinogalactane | |
Christensen et al. | Screw press extraction and ultrafiltration of flavonoids from kalanchoe leaves and stems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |